Increased renal echogenicity in a preterm neonate: Answer

Pediatric Nephrology

Volumn 20, Issue 11, 2005, Pages 1666-1668

  Bald, Martin ^a   Holder, Martin ^a   Zieger, Michael ^a   Vochem, Matthias ^a   Leichter, Heinz E ^a  

^a Olgahospital ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOSARTAN; TELMISARTAN; VALSARTAN;

ACUTE KIDNEY FAILURE; ARTICLE; CASE REPORT; CONGENITAL NEPHROTIC SYNDROME; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG WITHDRAWAL; FEMALE; FETOTOXICITY; FETUS; FETUS DISEASE; FOLLOW UP; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; KIDNEY BLOOD FLOW; KIDNEY DYSPLASIA; KIDNEY VEIN THROMBOSIS; LONG TERM CARE; PLACENTA CIRCULATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOGRAPHY;

EID: 27644510511     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1938-1     Document Type: Article

References (20)

1. Slovis TL, Bernstein J, Gruskin A (1993) Hyperechoic kidneys in the newborn and young infant. Pediatr Nephrol 7:294-302 10.1007/BF00853228
2. Mercato-Deane MG, Beeson JE, John SD (2002) US of renal insufficiency in neonates. Radiographics 22:1429-1438 12432113
3. Young BY, Veson E, Perlmutter S, Smith T (2004) Autosomal recessive polycystic kidney disease. eMedicine (www.emedicine.com/radio/topic69.htm)
4. Lanning P, Uhari M, Kouvalainen K, Lanning M (1989) Ultrasonic features of the congenital nephritic syndrome of the Finnish type. Acta Paediatr Scand 78:717-720 2688354
5. Haffner D, Wühl E, Zieger B, Grulich-Henn J, Mehls O, Schaefer F (1996) Bilateral renal venous thrombosis in a neonate associated with resistance to activated protein C. Pediatr Nephrol 10:737-739 10.1007/ s004670050204
6. Howlett DC, Greenwood KL, Jarosz JM, MacDonald LM, Saunders AJS (1997) The incidence of transient renal medullary hyperechogenicity in neonatal ultrasound examination. Br J Radiol 70:140-143 9135439
7. Lip GYH, Churchill D, Beevers M, Auckett A, Beevers DG (1997) Angiotensin-converting-enzyme inhibitors in early pregnancy. Lancet 350:1446-1447 10.1016/S0140-6736(05)64207-9
8. Pryde PG, Sedman AB, Nugent CE, Barr M (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582 8507813
9. Barr M (1994) Teratogen update: Angiotensin-converting enzyme inhibitors. Teratology 50:399-409 10.1002/tera.1420500606
10. Burrows RF, Burrows EA (1998) Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy. Aust N Z J Obstet Gynaecol 38:306-311 9761159
11. Shotan A, Widerhorn J, Hurst A (1994) Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96:451-456 10.1016/0002-9343(94)90172-4
12. Magee LA (2001) Treating hypertension in women of child-bearing age and during pregnancy. Drug Saf 24:457-474 11368252
13. Hilgers KF, Norwood VP, Gomez RA (1997) Angiotensin's role in renal development. Semin Nephrol 17:492-501 9316216
14. Lambot MA, Vermeylen D, Noel JC (2001) Angiotensin-II-receptor inhibitors in pregnancy. Lancet 357:1619-1620 10.1016/ S0140-6736(00)04757-7
15. Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Gubler MC (2001) Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 358:241-242 10.1016/S0140-6736(01)05426-5
16. Saji H, Yamanaka M, Hagiwara A, Ijiri R (2001) Losartan and fetal toxic effects. Lancet 357:363 10.1016/S0140-6736(00)03648-5
17. Düker G, Bökenkamp A, Garbe W, Lentze MJ (2002) Lorsartan-Fetopathie-eine Kasuistik. Nieren-Hochdruckkrankh 31:67-68
18. Briggs GG, Nageotte MP(2001) Fatal fetal outcome with the combined use of valsartan and atenolol. Ann Pharmacother 35:859-861 10.1345/aph.1A013
19. Pietrement C, Malot L, Santerne B, Roussel B, Motte J, Morville P (2003) Neonatal acute renal failure to maternal exposure to telmisartan, angiotensin II receptor antagonist. J Perinatol 23:254-255 10.1038/ sj.jp.7210871
20. Hinsberger A, Wingen AM, Hoyer PF (2001) Angiotensin-II-receptor inhibitors in pregnancy. Lancet 357:1620 10.1016/S0140-6736(00)04758-9